| | Cancer | Liver Cancer
Fibroadenoma and Fibrocystic Changes: Are They Cancerous?
No. Fibroadenomas are benign (non-cancerous) solid breast tumors composed of glandular and stromal tissue. Fibrocystic changes are also benign, encompassing a spectrum of histologic findings (cysts, fibrosis, adenosis, epithelial hyperplasia) that cause lumpiness, tenderness, and cyclical pain.
Key Points
- Fibroadenomas are the most common breast tumor in women under 30. They are mobile, rubbery, and well-circumscribed.
- Fibrocystic changes affect up to 50% of women of reproductive age and are hormone-responsive.
- Neither condition turns into cancer. However, complex fibroadenomas or fibrocystic changes with atypical hyperplasia slightly increase future breast cancer risk.
- Diagnosis is confirmed by ultrasound, mammogram, and/or core needle biopsy.
Management
- Simple fibroadenomas: clinical surveillance with imaging every 6–12 months; excision if growing, symptomatic, or patient preference.
- Fibrocystic changes: supportive care (supportive bra, NSAIDs, caffeine reduction, evening primrose oil); hormonal therapy for severe symptoms.
Bottom Line
Finding a breast lump is alarming, but fibroadenomas and fibrocystic changes are overwhelmingly benign. Always have new breast changes evaluated by a clinician for definitive diagnosis.
Liver Cancer - Related Articles
- Liver Function: Does the Liver Produce Mucus or Acid?
- Chondrosarcoma Prognosis: Grading, Staging, and Survival Statistics
- Right Liver Lobe Anatomy: Largest Segment, Functional Significance, and Clinical Relevance
- Liver Blood Processing: Filtration, Metabolism, Detoxification, and Synthesis
- Liver Regeneration: How the Liver Restores Itself After Resection
- Blood Donation After Cancer: Eligibility & Requirements
- Cirrhosis: Understanding Causes, Symptoms, and Complications
